Generated by GPT-5-mini| Machine-or-Transformation test | |
|---|---|
| Name | Machine-or-Transformation test |
| Type | Legal test |
| Introduced | 1972 |
| Jurisdiction | United States |
| Related | Patent law, Patentability |
Machine-or-Transformation test The Machine-or-Transformation test is a judicial criterion used in United States patent law to assess the patent eligibility of processes by asking whether a claimed process is tied to a particular machine or apparatus, or transforms a particular article into a different state or thing. Originating in precedent and refined through decisions of the United States Court of Appeals for the Federal Circuit, the test became a focal point in debates involving patents on software, business methods, and biotechnology. Its interpretation influenced rulings by the Supreme Court of the United States and guided policy discussions at institutions like the United States Patent and Trademark Office.
The test traces roots to decisions arising from disputes before the United States Court of Appeals for the Federal Circuit, the Supreme Court of the United States, and earlier rulings in the District of Columbia Circuit and Second Circuit. Key historical actors include judges and legal scholars associated with cases decided in the 1970s through the early 2010s, with involvement by litigants represented by firms that appeared before the Federal Circuit Bar Association and advocacy at hearings before committees of the United States Congress. Influential personalities who shaped debate include jurists with prior service on the United States Court of Federal Claims and academics from institutions such as Harvard Law School, Stanford Law School, Yale Law School, and Columbia Law School.
The Machine-or-Transformation test articulates two primary prongs that derive from statutory interpretation of the patent statutes adjudicated by the Supreme Court of the United States: the machine prong (connection to a particular machine or apparatus) and the transformation prong (conversion of an article into a different state or thing). Courts evaluated claims against standards informed by precedent from cases argued before judges appointed by presidents including Richard Nixon, Ronald Reagan, Bill Clinton, George W. Bush, and Barack Obama. The analytical framework intersected with doctrines developed in decisions authored by justices who previously participated in cases at the United States Court of Appeals for the Ninth Circuit and the Third Circuit.
Practitioners applied the test in prosecution and litigation before the United States Patent and Trademark Office, in appeals to the United States Court of Appeals for the Federal Circuit, and in petitions for certiorari to the Supreme Court of the United States. Industries affected included firms represented in courts by counsel from firms linked to major litigants such as IBM, Microsoft, Apple Inc., Google, Amazon (company), and Oracle Corporation. Trade associations and interest groups like the Computer & Communications Industry Association and the Biotechnology Industry Organization engaged in rulemaking comments and amicus briefs in leading cases.
Prominent decisions that addressed the test came from the Supreme Court of the United States and the United States Court of Appeals for the Federal Circuit. Cases involved parties including Bilski v. Kappos, litigants associated with entities such as State Street Bank and Trust Company, Alice Corporation, and counsel from firms with clients like eBay Inc. and AT&T Inc.. Other influential opinions referenced rulings from the District Court for the Eastern District of Virginia, the Southern District of New York, and appeals touching parties like Flook, Diehr, and later matters invoking doctrines discussed by entities such as Microsoft Corporation and Intel Corporation.
Scholars and practitioners critiqued the test in journals and briefs filed by academics from Harvard University, Stanford University, Massachusetts Institute of Technology, Yale University, and think tanks associated with policy analysts who had earlier affiliations with the American Enterprise Institute and the Brookings Institution. Alternative approaches proposed by commentators and opposing counsel included reliance on statutory text from the patent statutes, doctrinal frameworks advanced in amicus briefs by organizations like the Electronic Frontier Foundation and legal theories expounded by members of the Federalist Society and the American Bar Association.
The test had pronounced effects on patentability determinations for software companies including Microsoft, Apple Inc., Google, IBM, and Oracle Corporation as well as biotechnology firms such as Genentech, Amgen, Biogen, Gilead Sciences, and Novartis. Litigation strategies by counsel for startups and established firms often referenced the test in disputes litigated in venues like the Northern District of California and appealed to the United States Court of Appeals for the Federal Circuit, with potential certiorari petitions to the Supreme Court of the United States. Administrative policy discussions at the United States Patent and Trademark Office and congressional hearings before committees chaired by members from delegations including California's Congressional delegation and New York's Congressional delegation reflected the test's practical significance.